In the presented analysis, both SEC and mass photometry were used to measure aggregation levels of trastuzumab, a monoclonal antibody, and several trastuzumab biosimilars. The results of this short study demonstrate that SEC and mass photometry are complementary, highlighting the usefulness of mass photometry as an orthogonal technique for monitoring aggregation of biopharmaceuticals such as mAbs.